IDH1/IDH2 but Not TP53 Mutations Predict Prognosis in Bulgarian Glioblastoma Patients

Figure 2

Kaplan-Meier plots of overall survival in groups divided by two factors: IDH1/IDH2 mutation status and (a) primary versus secondary GBM and (b) age.

(a)

(b)